ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (361)	12/7/1998 3:24:00 PM
From: Czechsinthemail	Read Replies (1) of 4474

The floorless convertible looks like a bad news story. It seems to be an indication that the company is in fairly dire straits if they need to put a floorless conversion provision in the financing deal -- either that or they have financially naive management or management looking to accumulate lots of shares on the cheap when the stock price dives due to the floorless conversion -- neither of which seems a particularly attractive alternative. My guess is that the company is being overwhelmed by its current cash requirements and simply isn't getting enough cash coming in through milestones or new partnering agreements to meet it. Apart from a major blockbuster announcement, it is hard to see what will keep the stock from being undermined by short selling. Anyone seeing silver linings? Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next